Public Company News

CStone received China NMPA IND acceptance for lorlatinib in Chinese patients with ROS1-positive advanced NSCLC

SUZHOU, China, Oct. 20, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology therapies and precision medicines, today announced that the investigational new drug (...

2021-10-20 08:00 3837

SK hynix Announces Development of HBM3 DRAM

SEOUL, South Korea, Oct. 19, 2021 /PRNewswire/ -- SK hynix Inc. (or "the Company",www.skhynix.com ) announced that it has become the first in the industry to successfully develop the High Bandwidth Memory 3, the world's best-performing DRAM.

2021-10-20 08:00 2790

Japanese Alternative Meat venture Next Meats announces upgrade of signature barbecue meat: Next Yakiniku Short-rib 2.0

TOKYO, Oct. 19, 2021 /PRNewswire/ -- Next Meats Co. Ltd, a Tokyo-based food-tech venture known for developing the world's first plant-based barbecue meats, the "Next Yakiniku" series, just announced the launch of their newest version of the Short-Rib style product: the Next Yakiniku Short-Rib 2.0...

2021-10-20 07:49 3334

Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China

* China Phase I study of BBT-401 had its first subject dosed in Chengdu, China * The company seeks to accelerate its business development activities with Daewoong, their partner for the development and commercialization of BBT-401 in 22 Asian countries SEONGNAM, South Korea and CHENGDU, China, ...

2021-10-20 07:00 1802

Amcor to Report First Quarter 2022 Results

ZURICH, Switzerland, Oct. 19, 2021 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its results for the three months ended30 September 2021 after the US market closes on Tuesday2 November 2021.   A conference call and webcast to discuss the results will be held at 5.30pm US Eastern...

2021-10-20 05:36 4341

Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program

- Clinical trial to enroll patients with early-stage Multiple Systems Atrophy (MSA) - - Expanding bioMUSE Natural History Study - MELBOURNE, Australia and SAN FRANCISCO, Oct. 19, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology c...

2021-10-20 05:08 2093

China Liberal Announces Results of Annual General Meeting of Shareholders for Fiscal Year 2021

BEIJING, Oct. 19, 2021 /PRNewswire/ -- China Liberal Education Holdings Limited (Nasdaq: CLEU) ("China Liberal", the "Company", or "we"), a China-based company that provides smart campus solutions and other educational services, today announced the results of the Company's 2021 Annual General Mee...

2021-10-19 21:00 1673

E-Home Household Service Holdings Limited Dissolves the VIE Structure

FUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the "Company" or "E-Home"), a provider of integrated household services inChina, today announced that its indirectly wholly owned Chinese subsidiary, E-Home Household Service Technology Co., Ltd....

2021-10-19 20:30 3584

PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody

DAEJEON, South Korea, Oct. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the patent for PMC-309, one of the Company's first immuno-oncology assets, has been ...

2021-10-19 20:00 1725

Pingtan Marine Enterprise Receives Nasdaq's Determination Letter

FUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Pingtan Marine Enterprise Ltd. (Nasdaq: PME), ("Pingtan," or the "Company"), a fishing company based in the People's Republic of China, announced today that it received a determination notice letter datedOctober 13, 2021 (the "Determination Notice") fr...

2021-10-19 20:00 3899

Pismo Raises $108 Million Series B Led by SoftBank, Amazon and Accel to Enable Cloud-Native Financial Services Globally

Investors also include B3, Falabella Ventures, Headline, PruVen and Redpoint eventures. Funding will fuel the company's expansion and development of market-leading banking and payments technologies SÃO PAULO, Oct. 19, 2021 /PRNewswire/ -- Pismo, the cloud-native core banking and payments platfor...

2021-10-19 19:50 3689

Zenix Enters into Definitive Agreement for "Going Private" Transaction

BEIJING, Oct. 19, 2021 /PRNewswire/ -- China Zenix Auto International Limited (OTC: ZXAIY) (the "Company"), one of the largest commercial vehicle wheel manufacturers inChina in both the aftermarket and OEM market by sales volume, today announced that it has entered into an Agreement and Plan of M...

2021-10-19 19:33 3724

36Kr Announces Short-Form Video Marketing Collaboration with Intel

BEIJING, Oct. 19, 2021 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and pioneering platform dedicated to serving New Economy participants inChina, today announced that the Company has provided customized short-form video advertising solutions for ...

2021-10-19 19:00 1844

Carrier Acquires Cavius, an Innovative Residential Alarm Company

Strategic acquisition expands Carrier's Healthy Homes offering and strengthens its interconnected Fire & Security portfolio PALM BEACH GARDENS, Fla., Oct. 19, 2021 /PRNewswire/ -- Carrier Global Corporation (NYSE:CARR) the leading global provider of healthy, safe, sustainable and intelligent bui...

2021-10-19 18:55 4043

Spin Master Establishes Spin Master Ventures to Accelerate Growth in Key Strategic Areas

TORONTO, Oct. 19, 2021 /PRNewswire/ -- Spin Master Corp. ("Spin Master" or "the Company") announced today the creation of Spin Master Ventures ("SMV"). SMV's focus is to accelerate growth in each of the Company's three creative centres comprising Toys, Entertainment and Digital Games, through str...

2021-10-19 18:30 3412

Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, the clinical trial of its anti-FcRn antibody, batoclimab (HBM9161), has completed the first dosing of first patient in phase II trial for the treatment ...

2021-10-19 17:52 2242

Fosun Sports Group announces new entity to deepen global sports industry footprint

HONG KONG, Oct. 19, 2021 /PRNewswire/ -- On October 19, 2021, Fosun Sports Group (hereinafter referred to as 'Fosun Sports'), a global pan-sports industry operating group company and subsidiary of Fosun International's happiness segment, announced the formal establishment of Fosun Sports as a ho...

2021-10-19 17:00 3483

Ericsson reports third quarter results 2021

STOCKHOLM, Oct. 19, 2021 /PRNewswire/ -- Third quarter highlights * Group organic sales declined by -1% YoY. Sales in Mainland China in Networks and Digital Services declined bySEK -3.6 b. impacting the growth rate by -6%. Some impact was seen from disturbances in the supply chain. Reported sa...

2021-10-19 15:07 3463

FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick

SYDNEY, Oct. 19, 2021 /PRNewswire/ -- The iQ Group Global Ltd (NSX.IQG), on behalf of its subsidiary, Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce that one of its licensees, GBS Inc (Nasdaq: GBS); a life sciences company operating in theAsia Pacific region, under lice...

2021-10-19 15:01 2046

Clarivate Measures Research Performance of the World's Leading Economies in Annual G20 Scorecard Report

Web of Science data uncovers links between G20 nations' response to COVID-19 and research subject diversity LONDON, Oct. 19, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launched a new re...

2021-10-19 15:00 2964

Week's Top Stories